CRD HTA Database news

The CRD HTA database includes completed and ongoing health technology assessments from around the world. It is a valuable source for identifying grey literature as much of the information it contains is only available directly from individual funding agencies. Database content is supplied by the 52 members of the International Network of Agencies for Health Technology Assessment (INAHTA) and by 20 other international HTA organisations. All new content is checked, proof read and published on the database by CRD. Any study designated as a health technology assessment by the contributing organisation is eligible for inclusion on the database. Bibliographic details and contact information are provided for published projects, and the authors’ conclusions are included for some projects. Links to reports, project pages and/ or organisation websites are provided wherever possible. The CRD HTA database also contains records of ongoing HTA projects and records are updated when projects are completed. This enables funders and researchers to identify work already in progress and may help reduce unintended duplication of effort.


Family presence during resuscitation

Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Lavenberg JG., Holland S, Solano L, Tolbert M, Umscheid CA. Family presence during resuscitation. Philadelphia: Center […]


[Support for unaccompanied minors]

Record Status This is a bibliographic record of an ongoing health technology assessment being undertaken by a member of INAHTA. Links to the published report and any other relevant documentation will be added when available. Citation SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services. Stöd […]


Gainsharing and shared savings strategies in the healthcare setting: Evidence for effectiveness

Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institute of Health Economics. Gainsharing and shared savings strategies in the healthcare setting: Evidence for effectiveness. […]


Durvalumab (Imfinzi™) for the treatment of patients with stage III non-small-cell lung cancer after prior chemoradiotherapy

Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation McGahan L. Durvalumab (Imfinzi™) for the treatment of patients with stage III non-small-cell lung cancer after […]